GR3032646T3 - N-substituted piperidinyl bicyclic benzoate derivatives - Google Patents

N-substituted piperidinyl bicyclic benzoate derivatives

Info

Publication number
GR3032646T3
GR3032646T3 GR20000400344T GR20000400344T GR3032646T3 GR 3032646 T3 GR3032646 T3 GR 3032646T3 GR 20000400344 T GR20000400344 T GR 20000400344T GR 20000400344 T GR20000400344 T GR 20000400344T GR 3032646 T3 GR3032646 T3 GR 3032646T3
Authority
GR
Greece
Prior art keywords
6alkyl
substituted
halo
hydrogen
alk
Prior art date
Application number
GR20000400344T
Other languages
English (en)
Inventor
Daele Georges Henri Paul Van
Jean-Paul Rene Marie A Bosmans
Den Keybus Frans Maria Alf Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of GR3032646T3 publication Critical patent/GR3032646T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR20000400344T 1994-09-27 2000-02-11 N-substituted piperidinyl bicyclic benzoate derivatives GR3032646T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94202792 1994-09-27
US45548695A 1995-05-31 1995-05-31
PCT/EP1995/003691 WO1996010027A1 (en) 1994-09-27 1995-09-19 N-substituted piperidinyl bicyclic benzoate derivatives

Publications (1)

Publication Number Publication Date
GR3032646T3 true GR3032646T3 (en) 2000-06-30

Family

ID=26136613

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000400344T GR3032646T3 (en) 1994-09-27 2000-02-11 N-substituted piperidinyl bicyclic benzoate derivatives

Country Status (23)

Country Link
EP (1) EP0784620B1 (el)
JP (1) JP3953097B2 (el)
CN (1) CN1068880C (el)
AT (1) ATE187453T1 (el)
AU (1) AU699152B2 (el)
BR (1) BR9509036A (el)
CA (1) CA2200578C (el)
CZ (1) CZ289031B6 (el)
DE (1) DE69513846T2 (el)
DK (1) DK0784620T3 (el)
ES (1) ES2141383T3 (el)
FI (1) FI119640B (el)
GR (1) GR3032646T3 (el)
HU (1) HU218698B (el)
IL (1) IL115413A (el)
MY (1) MY113202A (el)
NO (1) NO313238B1 (el)
NZ (1) NZ293605A (el)
PL (1) PL182502B1 (el)
PT (1) PT784620E (el)
RU (1) RU2154064C2 (el)
WO (1) WO1996010027A1 (el)
ZA (1) ZA958081B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077973A2 (en) * 1998-05-14 2001-02-28 Egis Gyogyszergyar Rt. Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
PL214274B1 (pl) 2002-01-16 2013-07-31 Movetis N V N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania
US7834010B2 (en) 2003-12-23 2010-11-16 Serodus As Modulators of peripheral 5-HT receptors
EP1758580A4 (en) 2004-06-24 2008-01-16 Incyte Corp N-SUBSTITUTED PIPERIDINE AND ITS USE AS A MEDICAMENT
EP1945632B1 (en) 2005-11-08 2013-09-18 Vertex Pharmaceuticals Incorporated Heterocyclic modulators of atp-binding cassette transporters
EP2789606B1 (en) 2007-05-09 2017-11-15 Vertex Pharmaceuticals Incorporated Modulators of CFTR
NZ612635A (en) 2007-12-07 2015-06-26 Vertex Pharma Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
EP3683218B1 (en) 2007-12-07 2024-09-18 Vertex Pharmaceuticals Incorporated Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
CA2931134C (en) 2008-02-28 2019-07-30 Vertex Pharmaceuticals Incorporated Heteroaryl derivatives as cftr modulators
HRP20211752T1 (hr) 2010-04-07 2022-02-18 Vertex Pharmaceuticals Incorporated Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
MX2012011655A (es) * 2010-04-07 2012-11-23 Vertex Pharma Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo [d][1-3]dioxol-5-il]ciclopropanocarboxamido)-3-metilpiridin-2-il) benzoico.
US10231932B2 (en) 2013-11-12 2019-03-19 Vertex Pharmaceuticals Incorporated Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
SG11201703963QA (en) 2014-11-18 2017-06-29 Vertex Pharma Process of conducting high throughput testing high performance liquid chromatography

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
CN1166171A (zh) 1997-11-26
PL319997A1 (en) 1997-09-01
NZ293605A (en) 1998-07-28
DK0784620T3 (da) 2000-05-22
CZ91897A3 (en) 1997-12-17
ES2141383T3 (es) 2000-03-16
AU699152B2 (en) 1998-11-26
MX9702363A (es) 1997-10-31
EP0784620B1 (en) 1999-12-08
EP0784620A1 (en) 1997-07-23
JPH10506118A (ja) 1998-06-16
PT784620E (pt) 2000-05-31
NO971376L (no) 1997-05-05
FI971274A (fi) 1997-03-26
IL115413A (en) 2000-02-17
NO971376D0 (no) 1997-03-24
FI119640B (fi) 2009-01-30
WO1996010027A1 (en) 1996-04-04
RU2154064C2 (ru) 2000-08-10
CN1068880C (zh) 2001-07-25
CZ289031B6 (cs) 2001-10-17
MY113202A (en) 2001-12-31
DE69513846D1 (de) 2000-01-13
ZA958081B (en) 1997-03-26
DE69513846T2 (de) 2000-07-06
HU218698B (hu) 2000-11-28
JP3953097B2 (ja) 2007-08-01
AU3608195A (en) 1996-04-19
PL182502B1 (pl) 2002-01-31
CA2200578A1 (en) 1996-04-04
BR9509036A (pt) 1997-10-14
NO313238B1 (no) 2002-09-02
HUT77173A (hu) 1998-03-02
IL115413A0 (en) 1995-12-31
CA2200578C (en) 2006-11-07
ATE187453T1 (de) 1999-12-15
FI971274A0 (fi) 1997-03-26

Similar Documents

Publication Publication Date Title
GR3032646T3 (en) N-substituted piperidinyl bicyclic benzoate derivatives
TW369526B (en) Diazabicyclic neurokinin antagonists
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
YU95102A (sh) Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija
CA2036876A1 (fr) Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RS20050180A (en) Novel benzoimidazole derivatives useful as antiproliferative agensts
CA2037575A1 (en) N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives
MY132062A (en) Apolipoprotein-b synthesis inhibitors
BG104983A (en) Aryl fused azapolycyclic compounds
ZW9791A1 (en) New heterocyclic chemistry
PL322872A1 (en) Novel triazolones - inhibitors of b apolipoprotein synthesis
MY101775A (en) Substituted dipeptides, methods for their production, pharmaceutical, compositions containing them, method for making such pharmaceutical compositions
TW360653B (en) A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
HUT47263A (en) Process for production of 5-/3-alkyl-5-terc-butil/-4-hydroxi-phenil/-2-amino-6h-1,3,4-tiadiasines and medical compositions containing them
AP1396A (en) 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives.
MXPA04004365A (es) Novedosas sales mandelato de derivados de tetrahidrofurano tetraciclico sustituido.
AP2001002154A0 (en) Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.
JO1648B1 (en) Nitrogen compounds
JO1697B1 (en) Pyridine derivatives
ATE178064T1 (de) Phenyl-oxo-alkyl-(4-piperidinyl) benzoatderivate
MX9703074A (es) Inhibidores de sintesis de apoliproteina-b.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees